Clinical Trial Update: A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures [Phase 3]

View source ↗

Summary

This Phase 3 trial is evaluating the safety and tolerability of Staccato Alprazolam in participants 12 years and older with stereotypical prolonged seizures; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizure Disorders

Drugs mentioned

• Staccato Alprazolam (Alprazolam)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Stereotypical Prolonged Seizures | Phase 3 | Status: ENROLLING_BY_INVITATION